Suppr超能文献

细菌维生素 K 环氧化物还原酶同源物的结构。

Structure of a bacterial homologue of vitamin K epoxide reductase.

机构信息

Howard Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA.

出版信息

Nature. 2010 Jan 28;463(7280):507-12. doi: 10.1038/nature08720.

Abstract

Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain gamma-carboxylation of many blood coagulation factors. Here, we report the 3.6 A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant.

摘要

维生素 K 环氧化物还原酶(VKOR)生成维生素 K 氢醌,以维持许多血液凝血因子的γ-羧化。在这里,我们报告了来自聚球藻属的 VKOR 的细菌同源物的 3.6 A 晶体结构。该结构显示 VKOR 与天然融合的氧化还原伴侣(一种硫氧还蛋白样结构域)形成复合物,并对应于电子转移的捕获状态。VKOR 的催化核心是一个由四个跨膜螺旋束组成的结构,围绕一个醌,通过一个额外的跨膜片段与周质硫氧还蛋白样结构域相连。我们提出了 VKOR 如何利用新合成蛋白质中的半胱氨酸中的电子还原醌的途径,体外重新形成维生素 K 依赖性二硫键的实验证实了这一机制。我们的结果对哺乳动物 VKOR 的机制有影响,并解释了突变如何导致对 VKOR 抑制剂华法林(最常用的口服抗凝剂)的抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d412/2919313/ddb02c12e1a3/nihms165697f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验